Keiretsu Forum is a community of angel investor members, VCs,corporate investors and entrepreneurs who provide early-stage capital to high quality, diverse cos.
Human cardiac tissue was successfully 3D printed in space using the BioFabrication Facility aboard the @Space_Station. 💗🥳
Bioprinting tissues could lead to novel medical treatments like producing organs for patients awaiting transplants.
The world’s most powerful space telescope has done it again.
Webb has discovered what appears to be a new record-holder for the most distant known galaxy — shattering its own previous record. This galaxy existed only 290 million years after the big bang: https://t.co/6JN3L2CvRG
As the world struggles with how to dispose of plastic, some scientists hope plastic-munching microbes might hold part of the answer.
♻️ Learn more on #GlobalRecyclingDay: https://t.co/Up79nDF2LF @NewsfromScience
Being busy is not the same as being productive. It’s the difference between running on a treadmill and running to a destination. They’re both running, but being busy is running in place. https://t.co/CAwmhs5Yvd
On April 8, a solar #eclipse will cross Central and North America, and you can @DoNASAScience while it does.
From observing changes in animal behavior to recording temperature changes, we have several projects anybody with a smartphone can take part in: https://t.co/9QG6oNX8vs
The Kraken sent fans into a frenzy as they scored goal after goal at Climate Pledge Arena to take a 2-1 lead in their Western Conference semifinal. https://t.co/07XA4O8W6J
We are still in awe of the generosity shown to the Discovery Center of Idaho during Idaho Gives.💜Because of donors like you, we were able to raise $5,020 to further our mission of creating accessible learning for all. Thank you!! 💜✨
“If at some point Earth becomes uninhabitable there’s no way to escape. We are linked to this planet.”
Our world is changing - and it's even more important that we each do our part to help the planet. What are you doing to look after our world?
#EarthDay#EarthDay2023
A Cooley team earned a spot on this week's @litigationdaily’s Litigator of the Week Runners-Up and Shout Out list for securing a decisive victory on behalf of its client Silverback Therapeutics in a securities-fraud lawsuit, which was dismissed with prejudice.
@kinetabio announces first patient dosed in the Phase 1/2 clinical trial evaluating KVA12123 alone and in combination with pembrolizumab in patients with advanced solid tumors
https://t.co/7idKwUesY6